HHGA
TEVA icon

Halbert Hargrove Global Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$508 Buy
+15
New +$500 ﹤0.01% 531
2015
Q2 		– Sell
-4,350
Closed -$271K – 188
2015
Q1 		$271K Buy
+4,350
New +$253K 0.09% 150
2014
Q2 		– Sell
-6,772
Closed -$358K – 138
2014
Q1 		$358K Buy
6,772
+542
+9% +$25.1K 0.11% 66
2013
Q4 		$250K Buy
+6,230
New +$245K 0.08% 108

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Halbert Hargrove Global Advisors's TEVA Position: Q2 2026 in Review

Halbert Hargrove Global Advisors opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 15 shares worth $508. The stake represents ﹤0.01% of the portfolio and ranks #531 among its holdings. This is a return to the name: Halbert Hargrove Global Advisors previously reported a position in TEVA as recently as Q1 2015.

Halbert Hargrove Global Advisors first reported a position in TEVA in Q4 2013 and has held it in 4 quarters since. The position peaked at $358K in Q1 2014. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Halbert Hargrove Global Advisors held 15 shares of Teva Pharmaceuticals worth $508 as of Q2 2026.
  • Teva Pharmaceuticals was a new Halbert Hargrove Global Advisors position in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #531 holding.
  • Halbert Hargrove Global Advisors first reported a position in Teva Pharmaceuticals in Q4 2013 and has held it in 4 quarters since.
  • Halbert Hargrove Global Advisors's Teva Pharmaceuticals position peaked at $358K in Q1 2014.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.